Senior insider sale
Chief Operating Officer at TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$387.9K
4.56K shares
What this filing means
NEERVANNAN SESHADRI plans to sell 4.56K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $387.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/4/2026ACC: 0001959173-26-006753
Officer· Chief Operating Officer
Since Oct 2020
4.56K
Shares to sell
$387.9K
Approx. market value
4.56K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months7
ESPP Purchase
Cash
6/30/2023
1.71KRestricted Stock Vesting
Compensation
3/22/2023
460.00Restricted Stock Vesting
Compensation
3/21/2023
471.00Restricted Stock Vesting
Compensation
3/20/2023
478.00Restricted Stock Vesting
Compensation
3/17/2023
469.00Restricted Stock Vesting
Compensation
3/16/2023
489.00Restricted Stock Vesting
Compensation
3/15/2023
492.00Total acquired4.56K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/30/2023 | ESPP Purchase Cash | 1.71K | — |
3/22/2023 | Restricted Stock Vesting Compensation | 460.00 | — |
3/21/2023 | Restricted Stock Vesting Compensation | 471.00 | — |
3/20/2023 | Restricted Stock Vesting Compensation | 478.00 | — |
3/17/2023 | Restricted Stock Vesting Compensation | 469.00 | — |
3/16/2023 | Restricted Stock Vesting Compensation | 489.00 | — |
3/15/2023 | Restricted Stock Vesting Compensation | 492.00 | — |
| Total | 4.56K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.56K
Market value
$387.9K
9/4/2026
Total
Units
4.56K
Value
$387.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/4/2026 | 4.56K | $387.9K | NASDAQ | Planned |
| Total | 4.56K | $387.9K | ||